Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Total revenues	$ 4,650	$ 4,707
Gross profit	1,902	1,891
Selling, general, and administrative	1,038	1,062
Research and development	324	270
Total operating expenses	1,362	1,332
Operating income	540	559
Interest and other financial charges – net	122	136
Non-operating benefit (income) costs	(102)	(115)
Other (income) expense – net	8	(8)
Income before income taxes	512	546
Benefit (provision) for income taxes	(124)	(163)
Net income	388	383
Net (income) loss attributable to noncontrolling interests	(14)	(11)
Net income attributable to GE HealthCare	374	372
Deemed preferred stock dividend of redeemable noncontrolling interest	0	(183)
Net income attributable to GE HealthCare common stockholders	$ 374	$ 189
Earnings per share attributable to GE HealthCare common stockholders:
Basic earnings per share (in dollars per share)	$ 0.82	$ 0.42
Diluted earnings per share (in dollars per share)	$ 0.81	$ 0.41
Weighted-average number of shares outstanding:
Basic (in shares)	456	454
Diluted (in shares)	459	457
Cost of products
Total revenues	$ 3,045	$ 3,131
Cost of revenue	1,967	2,037
Cost of services
Total revenues	1,605	1,576
Cost of revenue	$ 782	$ 779